These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26887662)

  • 21. Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists.
    Cahn A; Raz I; Kleinman Y; Balicer R; Hoshen M; Lieberman N; Brenig N; Del Prato S; Cefalu WT
    Diabetes Care; 2015 Dec; 38(12):2293-300. PubMed ID: 26519337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study.
    Coons MJ; Greiver M; Aliarzadeh B; Meaney C; Moineddin R; Williamson T; Queenan J; Yu CH; White DG; Kiran T; Kane JJ
    BMJ Open Diabetes Res Care; 2017; 5(1):e000316. PubMed ID: 28761645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADA/EASD Updated Guidelines: Glycemic Control Is Only Part of the Management of Type 2 Diabetes.
    Shaughnessy AF
    Am Fam Physician; 2023 May; 107(5):Online. PubMed ID: 37192089
    [No Abstract]   [Full Text] [Related]  

  • 24. [New understanding of the problem of management of type 2 diabetes mellitus - novel prospects (ADA/EASD consensus, 2008)].
    Biryukova EV
    Probl Endokrinol (Mosk); 2009 Dec; 55(6):3-7. PubMed ID: 31569882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic control in patients with type 2 diabetes mellitus in Spain.
    Pérez A; Mediavilla JJ; Miñambres I; González-Segura D
    Rev Clin Esp (Barc); 2014 Nov; 214(8):429-36. PubMed ID: 25016415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-centred care in type 2 diabetes mellitus - Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report.
    Fritzen K; Stautner C; Schnell O
    Diabetes Res Clin Pract; 2019 Dec; 158():107897. PubMed ID: 31672502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation in daily clinical situations of Diascope
    Ampudia-Blasco FJ; García-Soidán FJ; Rubio Sánchez M; Phan TM
    Endocrinol Diabetes Nutr; 2017 Mar; 64(3):128-137. PubMed ID: 28440751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rethinking A1C targets for patients with mental illness?
    Falck-Ytter C; Kanuch SW; McCormick R; Purdum M; Dawson NV; Bolen SD; Sajatovic M
    J Fam Pract; 2016 Oct; 65(10):671. PubMed ID: 27846333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations.
    Bae JP; Kadziola ZA; Liu D; Chinthammit C; Boye KS; Mather KJ
    Diabetes Ther; 2022 Aug; 13(8):1499-1510. PubMed ID: 35764911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision Health Care Elements, Definitions, and Strategies for Patients with Diabetes: A Literature Review.
    Pranata S; Wu SV; Alizargar J; Liu JH; Liang SY; Lu YY
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34204428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes.
    Nolan JJ; Kahkoska AR; Semnani-Azad Z; Hivert MF; Ji L; Mohan V; Eckel RH; Philipson LH; Rich SS; Gruber C; Franks PW
    Diabetes Care; 2022 Feb; 45(2):261-266. PubMed ID: 35050364
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-diabetic Agents in Type 2 Diabetes: A Review of New Data Presented and Discussed on the EASD meeting in Rome, 2008.
    de Valk HW
    Rev Diabet Stud; 2008; 5(3):184-8. PubMed ID: 19099092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New glycemic targets for patients with diabetes from the Japan Diabetes Society.
    Araki E; Haneda M; Kasuga M; Nishikawa T; Kondo T; Ueki K; Kadowaki T
    Diabetol Int; 2016 Dec; 7(4):327-330. PubMed ID: 30603281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic inertia or individualization? Delay in clinical management of type 2 diabetes mellitus.
    Tanaka N; Kurose T; Seino Y
    Curr Med Res Opin; 2016 Sep; 32(9):1477-8. PubMed ID: 27181181
    [No Abstract]   [Full Text] [Related]  

  • 35. ADA-EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes in an Afro-Asian Context: Broadening the Perspective.
    Bhattacharya S; Kalra S
    touchREV Endocrinol; 2023 Nov; 19(2):4-6. PubMed ID: 38187081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes management today: Issues in achieving glycemic goals.
    Lansang MC
    Cleve Clin J Med; 2016 May; 83(5 Suppl 1):S2-3. PubMed ID: 27176679
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes.
    Zeng Z; Huang SY; Sun T
    Diabetes Ther; 2020 Nov; 11(11):2521-2538. PubMed ID: 32930968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487-493.
    Buse JB; Wexler DJ; Tsapas A; Rossing P; Mingrone G; Mathieu C; D'Alessio DA; Davies MJ
    Diabetes Care; 2020 Jul; 43(7):1670. PubMed ID: 32444453
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ; D'Alessio DA; Fradkin J; Kernan WN; Mathieu C; Mingrone G; Rossing P; Tsapas A; Wexler DJ; Buse JB
    Diabetologia; 2019 May; 62(5):873. PubMed ID: 30899969
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.